speb/financial-data huggingface dataset:
Stock screener scorecard for IGM.TO (quarterly, report date 2026-03-31)
Altman Z-score: 1.928666499699794 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 5.497599727437587%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.75489466327291%
Free cash flow margin: 12.000838950956819%
Revenue growth: -1.8605699448175295%
Rule of 40 score: 10.14026900613929
Market cap: 19361153024 (Large Cap ($10B-$200B))
P/E ratio: 9.731474079995262
Debt to equity: 0.2829
Free cash flow (dilution adjusted): 87679856.11510792
Operating income: 237561151.0791367
Net income: 205259712.23021585
Long score: 6 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for IR5B.IR (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 944033728 (Small Cap ($300M-$2B))
P/E ratio: 15.140664961636828
Debt to equity: 1.0324
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for KMX (annual, report date 2026-02-28)
Altman Z-score: 1.462037866502187 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 10.067048676347325%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -1.7106638982565012%
Free cash flow margin: 4.419590473074766%
Revenue growth: -1.792135517894831%
Rule of 40 score: 2.6274549551799353
Market cap: 6328040448 (Mid Cap ($2B-$10B))
P/E ratio: 25.696428571428573
Debt to equity: 3.1818
Free cash flow (dilution adjusted): 1143840000
Operating income: -409757000
Net income: 247290000
Long score: 3 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for LEHN.SW (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 441178816 (Small Cap ($300M-$2B))
P/E ratio: 41.739004629629626
Debt to equity: 0.9307
Long score: 1 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for MXL (quarterly, report date 2026-06-30)
Altman Z-score: 10.988388439410505 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 5.399601541576851%
Capitalized R&D asset: 108709570
ROCI (R&D adjusted): -0.224942919205513%
Rosenberg metric: 0.35324103683081903
Free cash flow margin: -15.290766196615872%
Revenue growth: 23.07709129078345%
Rule of 40 score: 7.786325094167578
Market cap: 6492725248 (Mid Cap ($2B-$10B))
P/E ratio: 1649.353585757102
Debt to equity: 0.3057
Free cash flow (dilution adjusted): -25818000
Operating income: -4121000
Net income: 1760000
Long score: 6 | Short score: 9
Recommendation: Neutral
Stock screener scorecard for NMAI (annual, report date 2025-12-31)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 16.984198286274317%
Capitalized R&D asset: 0
Free cash flow margin: 40.517358135009324%
Revenue growth: 119.63271723865014%
Rule of 40 score: 160.15007537365946
Market cap: 459936896 (Small Cap ($300M-$2B))
P/E ratio: 5.098765432098765
Debt to equity: 0.44507545074994925
Free cash flow (dilution adjusted): 33353465
Net income: 81265272
Long score: 6 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for NMAI (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 459936896 (Small Cap ($300M-$2B))
P/E ratio: 5.098765432098765
Debt to equity: 0.44507545074994925
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for NODK (quarterly, report date 2026-03-31)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 5.062431054053622%
Capitalized R&D asset: 0
Free cash flow margin: -3.6945068957417537%
Revenue growth: -2.2773851879785543%
Rule of 40 score: -5.9718920837203076
Market cap: 324630784 (Small Cap ($300M-$2B))
P/E ratio: 5.276737346698114
Debt to equity: 0.0051
Free cash flow (dilution adjusted): -2202000
Net income: 12508000
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for NSCI.V (quarterly, report date 2026-03-31)
Altman Z-score: -1.5199384559457516 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 220515.41248752826
ROCI (R&D adjusted): -3.621483858339119%
Rosenberg metric: -8.55650963100487
Free cash flow margin: -3.7592575232024%
Revenue growth: -1.5219371898509568%
Rule of 40 score: -5.281194713053357
Market cap: 17306932 (Nano Cap (< $50M))
Debt to equity: 1.1482999999999999
Free cash flow (dilution adjusted): -288489.20863309357
Operating income: -629496.4028776978
Net income: -921582.7338129497
Long score: 0 | Short score: 13
Recommendation: Short
Stock screener scorecard for NSIL.NS (annual, report date 2026-03-31)
Altman Z-score: 0.904472876947518 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 0.3737535651955023%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.44003162255232137%
Free cash flow margin: 54.08989306741152%
Revenue growth: -25.67040802388263%
Rule of 40 score: 28.419485043528894
Market cap: 28004929536 (Large Cap ($10B-$200B))
P/E ratio: 0.4694349006078153
Debt to equity: 0.0002
Free cash flow (dilution adjusted): 5198230.182280627
Operating income: 8011074.607884697
Net income: 6007746.92666384
Long score: 4 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for NSIL.NS (quarterly, report date 2026-03-31)
Altman Z-score: 0.8880652799600173 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 0.03633219088858092%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.057692937938499944%
Revenue growth: 160.48835418124995%
Rule of 40 score: 160.48835418124995
Market cap: 28004929536 (Large Cap ($10B-$200B))
P/E ratio: 0.4694349006078153
Debt to equity: 0.0002
Operating income: 1050339.1267486224
Net income: 583626.5366680797
Long score: 2 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for PEMC.V (quarterly, report date 2025-12-31)
Altman Z-score: 7.67626839739841 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -207.0397538345234%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -231.66265053125207%
Rule of 40 score: 0
Market cap: 13405210 (Nano Cap (< $50M))
Debt to equity: 0.0356
Free cash flow (dilution adjusted): -1310511.6788321168
Operating income: -1145238.6861313868
Net income: -1028416.0583941605
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for PGZ.V (quarterly, report date 2026-04-30)
Altman Z-score: 49.60894699147324 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -25.145118733509232%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -25.369393139841684%
Rule of 40 score: 0
Market cap: 71623328 (Micro Cap ($50M-$300M))
Debt to equity: 0
Free cash flow (dilution adjusted): -1340145.9854014597
Operating income: -1403649.6350364962
Net income: -1391240.8759124086
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for PLGC.OL (quarterly, report date 2026-03-31)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 1.2183101079551337%
Capitalized R&D asset: 0
Free cash flow margin: -1665.668076341935%
Rule of 40 score: -1665.668076341935
Market cap: 555000000 (Small Cap ($300M-$2B))
P/E ratio: 17.15787998772525
Debt to equity: 0.5357
Free cash flow (dilution adjusted): -24949352.87356322
Net income: 1038882.7586206896
Long score: 1 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for PPTA (quarterly, report date 2026-03-31)
Altman Z-score: 34.23720110467098 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -8.315251018470303%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -6.77245775364571%
Rule of 40 score: 0
Market cap: 2231685888 (Mid Cap ($2B-$10B))
Debt to equity: 0.0044
Free cash flow (dilution adjusted): -48146000
Operating income: -55567000
Net income: -48627000
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for RAN.AX (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 3185363 (Nano Cap (< $50M))
Debt to equity: 0.2324
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for RAN.AX (annual, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 3185363 (Nano Cap (< $50M))
Debt to equity: 0.2324
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for RAW.DE (quarterly, report date 2026-03-31)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 2.6993034055727554%
Capitalized R&D asset: 0
Free cash flow margin: 19.443176631675037%
Revenue growth: 506.41138354335567%
Rule of 40 score: 525.8545601750307
Market cap: 18600325120 (Large Cap ($10B-$200B))
P/E ratio: 13.055246570263254
Debt to equity: 0.9308554368049848
Free cash flow (dilution adjusted): 489655172.4137931
Net income: 596551724.137931
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for SADBHIN.NS (annual, report date 2026-03-31)
Altman Z-score: 0.2864135475315478 (Distress Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -13.198292875612555%
Capitalized R&D asset: 0
Free cash flow margin: 114.98402960139846%
Revenue growth: -0.25517799844190137%
Rule of 40 score: 114.72885160295655
Market cap: 796028992 (Small Cap ($300M-$2B))
P/E ratio: 1.671607577904984
Debt to equity: -4.510964274962195
Free cash flow (dilution adjusted): 94385120.8139042
Operating income: 37902501.05977109
Net income: 4779779.567613396
Long score: 5 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for SADBHIN.NS (quarterly, report date 2026-03-31)
Altman Z-score: -0.08285672104558212 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -18.156416438068643%
Capitalized R&D asset: 0
Revenue growth: -6.650078100711037%
Rule of 40 score: -6.650078100711037
Market cap: 796028992 (Small Cap ($300M-$2B))
P/E ratio: 1.6863970579318899
Debt to equity: -4.510964274962195
Operating income: 4810830.860534125
Net income: 9107990.674014414
Long score: 1 | Short score: 8
Recommendation: Short
Stock screener scorecard for TORO (quarterly, report date 2026-03-31)
Altman Z-score: 23.363458888951875 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 0.6113269514932358%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.4627169361530016%
Free cash flow margin: 42.661882290872356%
Revenue growth: -4.61105260033724%
Rule of 40 score: 38.05082969053512
Market cap: 175215792 (Micro Cap ($50M-$300M))
P/E ratio: 160
Debt to equity: 0
Free cash flow (dilution adjusted): 2924065.5172413792
Operating income: -1699678.1609195403
Net income: 605728.735632184
Long score: 7 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for USB (quarterly, report date 2026-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 99648102400 (Large Cap ($10B-$200B))
P/E ratio: 12.055888223552895
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for UZX (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 13914895 (Nano Cap (< $50M))
Debt to equity: 0.1834
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for VSL.AX (quarterly, report date 2025-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 772212864 (Small Cap ($300M-$2B))
P/E ratio: 41.97530864197531
Debt to equity: 2.0477000000000003
Long score: 0 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for WSBN.L (annual, report date 2025-12-31)
Altman Z-score: 15.413783182687041 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -26.52883566619446%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -9.789731074406268%
Rule of 40 score: 0
Market cap: 8543748 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -6315343.243243244
Operating income: -1626993.2432432433
Net income: -1631920.2702702703
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for WSBN.L (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 8543748 (Nano Cap (< $50M))
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 1724.T (annual, report date 2025-12-31)
Altman Z-score: 2.723880880227836 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 5.6745707277187245%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.049633146309883%
Free cash flow margin: 13.100686498855834%
Revenue growth: -10.11107820877903%
Rule of 40 score: 2.989608290076804
Market cap: 3093624202.433891 (Mid Cap ($2B-$10B))
P/E ratio: 12.783571084437567
Debt to equity: 0.23888530927835055
Free cash flow (dilution adjusted): 8784604.564925516
Operating income: 2244102.0395115404
Net income: 1547215.6511731986
Long score: 7 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 4707.T (annual, report date 2025-10-31)
Altman Z-score: 1.5259280041386662 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 2.4395524334140193%
Capitalized R&D asset: 453319.47698198626
ROCI (R&D adjusted): 3.618938489287217%
Rosenberg metric: -2.5509651989197595
Free cash flow margin: -5.0872292964700225%
Revenue growth: 3.256309937882623%
Rule of 40 score: -1.8309193585873995
Market cap: 1920954007 (Small Cap ($300M-$2B))
P/E ratio: 9.236199494184564
Debt to equity: 0.5504476545517185
Free cash flow (dilution adjusted): -1146224.8213125407
Operating income: 949363.2228719947
Net income: 1351403.50877193
Long score: 1 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for 6288.HK (annual, report date 2025-08-31)
Altman Z-score: 8.109575573908314 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 24.118059258761665%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 19.082400573665005%
Free cash flow margin: 11.816656124220309%
Revenue growth: 8.141138124720197%
Rule of 40 score: 19.957794248940505
Market cap: 14038970844912.309 (Mega Cap (>= $200B))
P/E ratio: 30.575801192439798
Debt to equity: 0.2206229860365199
Free cash flow (dilution adjusted): 2737448055.044622
Operating income: 3832420464.609306
Net income: 3127958307.786634
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 7048.T (annual, report date 2025-12-31)
Altman Z-score: 0.9554248285908253 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 16.431149377747836%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.53926198854508%
Free cash flow margin: 20.08483012693962%
Revenue growth: 6.822397129782256%
Rule of 40 score: 26.907227256721878
Market cap: 6421998022.275816 (Mid Cap ($2B-$10B))
P/E ratio: 45.69613711887842
Debt to equity: 0
Free cash flow (dilution adjusted): 5883332.267757816
Operating income: 672111.7575602583
Net income: 898516.718879867
Long score: 6 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for AFG (annual, report date 2025-12-31)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 20.654351212997994%
Capitalized R&D asset: 0
Free cash flow margin: 18.883961566888395%
Revenue growth: -1.9328340178787147%
Rule of 40 score: 16.95112754900968
Market cap: 11073713142.24 (Large Cap ($10B-$200B))
P/E ratio: 13.151678316199524
Debt to equity: 0.3775933609958506
Free cash flow (dilution adjusted): 1533000000
Net income: 842000000
Long score: 6 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for ARH.V (annual, report date 2024-02-29)
Altman Z-score: -11.581249154275914 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Free cash flow margin: -30.104762777383616%
Revenue growth: 98.15263147593076%
Rule of 40 score: 68.04786869854715
Market cap: 2278997.96 (Nano Cap (< $50M))
Debt to equity: -0.20982849196743358
Free cash flow (dilution adjusted): -649880.1470588235
Operating income: -1464976.4705882352
Net income: -1503586.0294117646
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for AZT.V (annual, report date 2025-12-31)
Altman Z-score: 26.466752029134938 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -21.236180718772047%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -6.4577676897398755%
Rule of 40 score: 0
Market cap: 58553273.68 (Micro Cap ($50M-$300M))
Debt to equity: 0
Free cash flow (dilution adjusted): -3527052.5547445253
Operating income: -1208698.5401459853
Net income: -1362959.8540145985
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for BNE.TO (annual, report date 2025-12-31)
Altman Z-score: 0.03132091350327168 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.24696830573409748%
Free cash flow margin: 1.6342980707940324%
Revenue growth: -7.582308847273714%
Rule of 40 score: -5.9480107764796815
Market cap: 163897414.79999998 (Micro Cap ($50M-$300M))
Debt to equity: 0.3379773653722377
Free cash flow (dilution adjusted): 2956934.3065693425
Operating income: -1651094.8905109488
Net income: -12499999.999999998
Long score: 4 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for CSR (annual, report date 2025-12-31)
Altman Z-score: 0.21843600345614733 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 19.039106763609194%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.3786255216866872%
Free cash flow margin: 34.717278979178694%
Revenue growth: 4.858170838713632%
Rule of 40 score: 39.57544981789233
Market cap: 1091196431.12 (Small Cap ($300M-$2B))
P/E ratio: 47.5176986204494
Debt to equity: 1.2073978783478923
Free cash flow (dilution adjusted): 95008000
Operating income: 23602000
Net income: 22964000
Long score: 5 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for DHY (annual, report date 2025-10-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 5.57180528748707%
Capitalized R&D asset: 0
Free cash flow margin: 39.95139275760617%
Revenue growth: -65.88290966760341%
Rule of 40 score: -25.931516909997242
Market cap: 269385021.75 (Micro Cap ($50M-$300M))
P/E ratio: 21.810583234792972
Debt to equity: 0.4285617147207128
Free cash flow (dilution adjusted): 5152633
Net income: 12351115
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ENLT (annual, report date 2025-12-31)
Altman Z-score: 1.9470382492076934 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -108.50878143580628%
Capitalized R&D asset: 6541425.886122253
ROCI (R&D adjusted): 3.2858383095995696%
Rosenberg metric: 16.893418155775983
Free cash flow margin: -264.5521619059396%
Revenue growth: 67.58532248209049%
Rule of 40 score: -196.96683942384914
Market cap: 20210969877.2004 (Large Cap ($10B-$200B))
P/E ratio: 125.7667600726836
Debt to equity: 2.567032158392892
Free cash flow (dilution adjusted): -484400000
Operating income: 71640251.57232705
Net income: 50535220.12578616
Long score: 1 | Short score: 8
Recommendation: Short
Stock screener scorecard for FRED.V (annual, report date 2025-09-30)
Altman Z-score: -68.26485718268007 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 27237441.42 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -973366.1870503598
Operating income: -1241421.582733813
Net income: -849027.3381294964
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for HAW.DE (annual, report date 2025-12-31)
Altman Z-score: 2.3528647027566576 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 4.225153516966181%
Earnings yield: 4.3161629567417945%
Return on net tangible assets: 39.14357615541323%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.465173805009071%
Free cash flow margin: 6.409765484219738%
Revenue growth: 9.770811695661559%
Rule of 40 score: 16.180577179881297
Market cap: 164306440.86999997 (Micro Cap ($50M-$300M))
P/E ratio: 14.934233854753678
Debt to equity: 1.305271790625274
Free cash flow (dilution adjusted): 46869411.76470588
Operating income: 14101176.470588235
Net income: 12943529.411764706
Long score: 6 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for IMAX (annual, report date 2025-12-31)
Altman Z-score: 4.418545507423309 (Safe Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 16.940429101374658%
Earnings yield: 2.634476179177033%
Return on net tangible assets: 29.235406871016888%
Capitalized R&D asset: 9163671.558368638
ROCI (R&D adjusted): 13.268003640208962%
Rosenberg metric: 13.084860630143133
Free cash flow margin: 14.218989205581503%
Revenue growth: 21.569495596663003%
Rule of 40 score: 35.788484802244504
Market cap: 2776941410.8128004 (Mid Cap ($2B-$10B))
P/E ratio: 60.99682403050566
Debt to equity: 0.6513666235712466
Free cash flow (dilution adjusted): 42575182.481751814
Operating income: 68399270.0729927
Net income: 33230656.934306566
Long score: 10 | Short score: 1
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for MAX (annual, report date 2025-12-31)
Altman Z-score: 2.5554899909247233 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 132.9691300280636%
Earnings yield: 4.353412922842626%
Return on net tangible assets: -62.907842014882654%
Capitalized R&D asset: 40729020
ROCI (R&D adjusted): 13.383023063824636%
Rosenberg metric: 1.2128111718275654
Free cash flow margin: 3.1364044540229883%
Revenue growth: 28.783953815409667%
Rule of 40 score: 31.920358269432654
Market cap: 700104907.25 (Small Cap ($300M-$2B))
P/E ratio: 26.161388111430814
Debt to equity: -5.254812632732754
Free cash flow (dilution adjusted): 34927000
Operating income: 35536000
Net income: 26761000
Long score: 8 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for MTL.TO (annual, report date 2025-12-31)
Altman Z-score: 1.9183329484180949 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 10.52362896536458%
Earnings yield: 3.393517066996262%
Return on net tangible assets: 31.897461734081862%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.325989091853518%
Free cash flow margin: 9.790724029616966%
Revenue growth: 11.955903808237629%
Rule of 40 score: 21.746627837854597
Market cap: 1481149867.23 (Small Cap ($300M-$2B))
P/E ratio: 16.256721185709583
Debt to equity: 0.9246673055895818
Free cash flow (dilution adjusted): 152481021.89781022
Operating income: 123536496.35036495
Net income: 66503649.63503649
Long score: 7 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for SGL.DE (annual, report date 2025-12-31)
Altman Z-score: 0.5355490959038413 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 8.434437704153057%
Earnings yield: 14.912658009986535%
Return on net tangible assets: -18.090569561157796%
Capitalized R&D asset: 52355870.09803922
ROCI (R&D adjusted): 6.890480676492516%
Rosenberg metric: -0.20091554131380182
Free cash flow margin: 3.0110562220653962%
Revenue growth: -6.44720553848976%
Rule of 40 score: -3.4361493164243635
Market cap: 382708158.00999993 (Small Cap ($300M-$2B))
Debt to equity: 0.5471092077087795
Free cash flow (dilution adjusted): 30117647.05882353
Operating income: 85058823.52941176
Net income: -92117647.05882353
Long score: 5 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for 0552.HK (annual, report date 2025-12-31)
Altman Z-score: 1.7987888601488196 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 11.20635950681376%
Earnings yield: 3.8703952466916167%
Return on net tangible assets: 9.893848350168625%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.44296216776685%
Free cash flow margin: 0.11945824727452102%
Revenue growth: 4.350027936790347%
Rule of 40 score: 4.469486184064868
Market cap: 28673716224 (Large Cap ($10B-$200B))
P/E ratio: 0.9061696658097687
Debt to equity: 0.04
Free cash flow (dilution adjusted): 25614000
Operating income: 397187000
Net income: 535676857.14285713
Long score: 5 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 0917.HK (annual, report date 2025-12-31)
Altman Z-score: 2.5838291964711386 (Grey Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 15.298381886071915%
Earnings yield: 5.659885403947515%
Return on net tangible assets: 16.495308231852825%
Capitalized R&D asset: 34217739.722724535
ROCI (R&D adjusted): 16.01220911117%
Rosenberg metric: 2.6690836680742946
Free cash flow margin: 20.841379857675726%
Revenue growth: 29.49054764571001%
Rule of 40 score: 50.331927503385735
Market cap: 2050315392 (Mid Cap ($2B-$10B))
P/E ratio: 2.5706940874035986
Debt to equity: 0.2682
Free cash flow (dilution adjusted): 49520428.571428575
Operating income: 43768714.28571428
Net income: 41446000
Long score: 10 | Short score: 1
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 1666.HK (annual, report date 2025-12-31)
Altman Z-score: 2.62445886305934 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 6.921084587985196%
Earnings yield: 2.545894685499847%
Return on net tangible assets: 12.080837375935898%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.723752707996558%
Free cash flow margin: 22.29558712960999%
Revenue growth: -6.858306589925664%
Rule of 40 score: 15.437280539684327
Market cap: 4405897216 (Mid Cap ($2B-$10B))
P/E ratio: 1.4781491002570692
Debt to equity: 0.1953
Free cash flow (dilution adjusted): 206516857.14285713
Operating income: 114591428.57142857
Net income: 94376285.71428572
Long score: 7 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for 1970.HK (annual, report date 2025-12-31)
Altman Z-score: 28.139866053687676 (Safe Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 16.816436859283115%
Earnings yield: 0.21407441025018498%
Return on net tangible assets: 15.525660378552692%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 13.816321829575863%
Free cash flow margin: 49.37514045904459%
Revenue growth: 31.76923660311933%
Rule of 40 score: 81.14437706216393
Market cap: 2727652352 (Mid Cap ($2B-$10B))
P/E ratio: 2.2288464693978014
Debt to equity: 0.0033861509590402323
Free cash flow (dilution adjusted): 7218857.142857143
Operating income: 6683428.571428572
Net income: 5383000
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 2569.HK (annual, report date 2025-12-31)
Altman Z-score: 4.472941860857797 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 14.706571936820959%
Earnings yield: 0.8302563642993102%
Return on net tangible assets: -2.9973801357221386%
Capitalized R&D asset: 957881.8565400845
ROCI (R&D adjusted): 11.939624961769253%
Free cash flow margin: -3.969081387207143%
Revenue growth: 25.430545311155967%
Rule of 40 score: 21.461463923948823
Market cap: 1210000000 (Small Cap ($300M-$2B))
P/E ratio: 1.799485861182519
Debt to equity: 0.0802
Free cash flow (dilution adjusted): -5134142.857142857
Operating income: 9767285.714285715
Net income: 7978714.285714285
Long score: 7 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 2587.HK (annual, report date 2025-12-31)
Altman Z-score: 0.30302142564015755 (Distress Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 30.127362387823926%
Earnings yield: 0.5164515565853122%
Return on net tangible assets: 54.61040774529883%
Capitalized R&D asset: 37846723.43712585
ROCI (R&D adjusted): 19.068981864506956%
Rosenberg metric: 1.3486616671601361
Free cash flow margin: 2.5730263587363478%
Revenue growth: 35.702613490692%
Rule of 40 score: 38.27563984942835
Market cap: 1827416064 (Small Cap ($300M-$2B))
P/E ratio: 8.02423797282409
Debt to equity: 0.1456
Free cash flow (dilution adjusted): 5743428.571428572
Operating income: 8282571.428571428
Net income: 7954571.428571428
Long score: 13 | Short score: 2
Recommendation: Long
Stock screener scorecard for 3182.T (annual, report date 2026-03-31)
Altman Z-score: 3.2880361917900456 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 23.735446313065975%
Earnings yield: 0.05894358367362388%
Return on net tangible assets: 207.12166172106828%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 12.18617162592986%
Free cash flow margin: 2.9468735457542987%
Revenue growth: -8.072163122815637%
Rule of 40 score: -5.125289577061338
Market cap: 55121022976 (Large Cap ($10B-$200B))
P/E ratio: 0.06818546230626975
Debt to equity: 1.4562
Free cash flow (dilution adjusted): 46352602.6026026
Operating income: 45914664.66466466
Net income: 28803803.8038038
Long score: 10 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 3600.HK (annual, report date 2025-12-31)
Altman Z-score: 5.960894537896818 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 33.2751530626326%
Earnings yield: 1.3768042689630717%
Return on net tangible assets: 41.67586825360996%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 18.780236201639667%
Free cash flow margin: 18.463602085256355%
Revenue growth: 10.78756275083036%
Rule of 40 score: 29.251164836086716
Market cap: 7118710784 (Mid Cap ($2B-$10B))
P/E ratio: 1.042336118251928
Debt to equity: 0.1985
Free cash flow (dilution adjusted): 88675578.40616965
Operating income: 96081619.53727506
Net income: 77281362.46786632
Long score: 12 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 4401.T (annual, report date 2026-03-31)
Altman Z-score: 3.363208809257047 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 11.226937095159856%
Earnings yield: 0.06336694117323517%
Return on net tangible assets: 10.236006508210746%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 9.360983268774827%
Free cash flow margin: 4.3794095971077605%
Revenue growth: -4.228615412499534%
Rule of 40 score: 0.1507941846082268
Market cap: 391976910848 (Mega Cap (>= $200B))
P/E ratio: 0.08121502062312591
Debt to equity: 0.16879999999999998
Free cash flow (dilution adjusted): 114132882.88288288
Operating income: 260354104.1041041
Net income: 198423423.4234234
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 6378.T (annual, report date 2026-03-31)
Altman Z-score: 3.32119858019331 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 15.3635533921509%
Earnings yield: 0.11983906355109183%
Return on net tangible assets: 7.645140882768018%
Capitalized R&D asset: 3271103.1670315154
ROCI (R&D adjusted): 11.463380841315066%
Rosenberg metric: 0.7475007176293977
Free cash flow margin: 5.408980408980408%
Revenue growth: -0.9364004388785889%
Rule of 40 score: 4.472579970101819
Market cap: 23137259520 (Large Cap ($10B-$200B))
P/E ratio: 0.08253951848598119
Debt to equity: 0.0956
Free cash flow (dilution adjusted): 9465715.715715716
Operating income: 18956456.456456456
Net income: 14132882.882882882
Long score: 9 | Short score: 0
Recommendation: Long
Stock screener scorecard for 7414.T (annual, report date 2026-03-31)
Altman Z-score: 2.2966214245656427 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 4.4718668629004865%
Earnings yield: 0.03304815654415203%
Return on net tangible assets: -4.499649491763055%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.110836477169247%
Free cash flow margin: 0.9833474902712205%
Revenue growth: -12.874401353792175%
Rule of 40 score: -11.891053863520954
Market cap: 35060641792 (Large Cap ($10B-$200B))
Debt to equity: 0.6402
Free cash flow (dilution adjusted): 15571821.821821822
Operating income: 29654654.654654656
Net income: -13257007.007007007
Long score: 4 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for 7868.T (annual, report date 2026-03-31)
Altman Z-score: 3.9770582385244264 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 11.794764104717904%
Earnings yield: 0.059272420768378534%
Return on net tangible assets: 11.294794339154182%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 10.900152019924313%
Free cash flow margin: 48.43767251849398%
Revenue growth: -11.462534279880632%
Rule of 40 score: 36.975138238613354
Market cap: 77483745280 (Large Cap ($10B-$200B))
P/E ratio: 0.09500457738686613
Debt to equity: 0.32159999999999994
Free cash flow (dilution adjusted): 109784784.78478478
Operating income: 42167167.167167164
Net income: 29842342.342342343
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 7952.T (annual, report date 2026-03-31)
Altman Z-score: 2.400644951984209 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0.25614641942334215%
Earnings yield: 0.0025559905365992058%
Return on net tangible assets: 0.8369289477678276%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.19944088367653076%
Free cash flow margin: -5.156213132729115%
Revenue growth: -7.5094443232282995%
Rule of 40 score: -12.665657455957415
Market cap: 28086898688 (Large Cap ($10B-$200B))
P/E ratio: 0.13294956481050244
Debt to equity: 0.2419
Free cash flow (dilution adjusted): -23241991.991991993
Operating income: 731981.981981982
Net income: 7138388.388388388
Long score: 3 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for 9923.HK (annual, report date 2025-12-31)
Altman Z-score: 1.0590073119084709 (Distress Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 18.140885914747283%
Earnings yield: 1.490562657375576%
Return on net tangible assets: 4.182358309255374%
Capitalized R&D asset: 59825496.44529218
ROCI (R&D adjusted): 5.355751861485372%
Rosenberg metric: 0.3921620695253725
Free cash flow margin: 3.4493872582335756%
Revenue growth: 11.846401712318594%
Rule of 40 score: 15.29578897055217
Market cap: 1956785664 (Small Cap ($300M-$2B))
P/E ratio: 3.770351328191945
Debt to equity: 0.3444
Free cash flow (dilution adjusted): 16313285.714285715
Operating income: 32600571.42857143
Net income: 13177714.285714285
Long score: 7 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for BRBR (quarterly, report date 2026-03-31)
Altman Z-score: 2.4003814778180432 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 13.608247422680412%
Earnings yield: 2.448526918719116%
Return on net tangible assets: -5.439576595119083%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 9.104704097116842%
Free cash flow margin: -3.140136963420745%
Revenue growth: 11.42750790991997%
Rule of 40 score: 8.287370946499227
Market cap: 1505798144 (Small Cap ($300M-$2B))
P/E ratio: 12.472868217054263
Debt to equity: -2.3804740859783045
Free cash flow (dilution adjusted): -18800000
Operating income: 66000000
Net income: 33900000
Long score: 3 | Short score: 8
Recommendation: Short
Stock screener scorecard for CAPD.L (annual, report date 2025-12-31)
Altman Z-score: 2.3549835892968662 (Grey Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 10.214469729066561%
Earnings yield: 32.83363881883422%
Return on net tangible assets: 21.214928002184426%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 10.284101591640098%
Free cash flow margin: 9.450075916419639%
Revenue growth: 7.416899658278966%
Rule of 40 score: 16.866975574698607
Market cap: 229087104 (Micro Cap ($50M-$300M))
P/E ratio: 0.05873180873180872
Debt to equity: 0.3368
Free cash flow (dilution adjusted): 44156756.75675676
Operating income: 68743243.24324325
Net income: 95928378.37837838
Long score: 12 | Short score: 1
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for DKSH.SW (annual, report date 2025-12-31)
Altman Z-score: 3.699756995934444 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 20.525853413654612%
Earnings yield: 9.080895858178442%
Return on net tangible assets: 31.604860674628117%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 12.570616040890052%
Free cash flow margin: 2.511155673585894%
Revenue growth: 13.687855604736873%
Rule of 40 score: 16.199011278322768
Market cap: 4240278784 (Mid Cap ($2B-$10B))
P/E ratio: 21.352022986720513
Debt to equity: 0.4301
Free cash flow (dilution adjusted): 351898734.17721516
Operating income: 414050632.9113924
Net income: 266962025.3164557
Long score: 14 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for EAPI.PA (annual, report date 2025-12-31)
Altman Z-score: 1.2324515787147383 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0.17712023338195454%
Earnings yield: 2.82584636641936%
Return on net tangible assets: -19.395929087327644%
Capitalized R&D asset: 60977230.39215686
ROCI (R&D adjusted): 0.27954513136842507%
Rosenberg metric: 0.8193342453260377
Free cash flow margin: 5.864414731409806%
Revenue growth: 4.758101674090005%
Rule of 40 score: 10.62251640549981
Market cap: 120036056 (Micro Cap ($50M-$300M))
Debt to equity: 0.083
Free cash flow (dilution adjusted): 58823529.41176471
Operating income: 2000000
Net income: -248470588.23529413
Long score: 4 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for EICHERMOT.NS (annual, report date 2026-03-31)
Altman Z-score: 19.177062495989706 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 66.72946409413136%
Earnings yield: 0.025732480951094105%
Return on net tangible assets: 21.755561208022417%
Capitalized R&D asset: 4350326.181283003
ROCI (R&D adjusted): 18.09113084311715%
Rosenberg metric: 20.02331833648639
Free cash flow margin: 15.121224742216%
Revenue growth: 12.361522178531906%
Rule of 40 score: 27.482746920747907
Market cap: 2093867204608 (Mega Cap (>= $200B))
P/E ratio: 0.3463624443903157
Debt to equity: 0.020499999999999997
Free cash flow (dilution adjusted): 368216405.25646466
Operating income: 524025010.5977109
Net income: 584488130.5637982
Long score: 11 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for EICHERMOT.NS (quarterly, report date 2026-03-31)
Altman Z-score: 18.272203581118344 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 17.30105113716874%
Earnings yield: 0.006671700048318737%
Return on net tangible assets: 7.488046101329732%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.723801915873422%
Revenue growth: -5.481162912304844%
Rule of 40 score: -5.481162912304844
Market cap: 2093867204608 (Mega Cap (>= $200B))
P/E ratio: 0.3463624443903157
Debt to equity: 0.020499999999999997
Operating income: 135864773.20898685
Net income: 161079906.74014413
Long score: 5 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for FLXS (quarterly, report date 2026-03-31)
Altman Z-score: 3.833533243313376 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 3.8064109923890297%
Earnings yield: 2.058815021595172%
Return on net tangible assets: 4.04040949148152%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.5448058807044776%
Free cash flow margin: 17.798045602605864%
Revenue growth: -2.641882806619929%
Rule of 40 score: 15.156162795985935
Market cap: 306489696 (Small Cap ($300M-$2B))
P/E ratio: 8.16970802919708
Debt to equity: 0.2909
Free cash flow (dilution adjusted): 20490000
Operating income: 8222000
Net income: 6445000
Long score: 7 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for GPTHEALTH.NS (quarterly, report date 2026-03-31)
Altman Z-score: 4.770020922330512 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 4.637963321044114%
Earnings yield: 0.012851344934726516%
Return on net tangible assets: 8.00014129860858%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.261657052660596%
Revenue growth: 0.05495589213437661%
Rule of 40 score: 0.05495589213437661
Market cap: 13099232256 (Large Cap ($10B-$200B))
P/E ratio: 0.23577652695511922
Debt to equity: 0.33840000000000003
Operating income: 1739953.3700720645
Net income: 1543662.5688851208
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for GPTHEALTH.NS (annual, report date 2026-03-31)
Altman Z-score: 5.814645947236471 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 16.580474519620143%
Earnings yield: 0.04594288106295605%
Return on net tangible assets: 10.583005495772197%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 15.235199436008303%
Free cash flow margin: 8.329081530039465%
Revenue growth: 5.5791928701262306%
Rule of 40 score: 13.908274400165695
Market cap: 13099232256 (Large Cap ($10B-$200B))
P/E ratio: 0.23577652695511922
Debt to equity: 0.33840000000000003
Free cash flow (dilution adjusted): 4169383.213225943
Operating income: 6220241.627808393
Net income: 4474406.528189911
Long score: 9 | Short score: 0
Recommendation: Long
Stock screener scorecard for IKIO.NS (quarterly, report date 2026-03-31)
Altman Z-score: 7.084596710672658 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 3.0156400889399038%
Earnings yield: 0.011354299667232481%
Return on net tangible assets: 4.352202270714227%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.760801340286463%
Revenue growth: 8.050595615402909%
Rule of 40 score: 8.050595615402909
Market cap: 15828634624 (Large Cap ($10B-$200B))
P/E ratio: 0.2344538097815711
Debt to equity: 0.1144
Operating income: 1859898.2619754134
Net income: 1857036.8800339126
Long score: 4 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for IKIO.NS (annual, report date 2026-03-31)
Altman Z-score: 7.776433634238889 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 8.265259482512723%
Earnings yield: 0.031119838649205103%
Return on net tangible assets: -1.4802587433234011%
Capitalized R&D asset: 447627.017583643
ROCI (R&D adjusted): 7.572712332588514%
Rosenberg metric: 19.393663517561272
Free cash flow margin: -11.473173714456578%
Revenue growth: 11.066723558062106%
Rule of 40 score: -0.406450156394472
Market cap: 15828634624 (Large Cap ($10B-$200B))
P/E ratio: 0.2344538097815711
Debt to equity: 0.1144
Free cash flow (dilution adjusted): -7238130.563798219
Operating income: 5097604.917337855
Net income: 4403878.762187367
Long score: 7 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for INSE (quarterly, report date 2026-03-31)
Altman Z-score: -0.8669624835244931 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 5.707196029776675%
Earnings yield: 3.5409966741727583%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.62182958107723%
Free cash flow margin: 31.818181818181817%
Revenue growth: -25.906735751295333%
Rule of 40 score: 5.911446066886484
Market cap: 177124368 (Micro Cap ($50M-$300M))
Debt to equity: -28.35483870967742
Free cash flow (dilution adjusted): 18200000
Operating income: 9200000
Net income: -500000
Long score: 4 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for JAYNECOIND.NS (annual, report date 2026-03-31)
Altman Z-score: 3.73715782351006 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 26.16216987647525%
Earnings yield: 0.10595729941102457%
Return on net tangible assets: 23.34389971542812%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 24.10236543992487%
Free cash flow margin: 17.545170797916942%
Revenue growth: 7.758113704632044%
Rule of 40 score: 25.303284502548987
Market cap: 95992889344 (Large Cap ($10B-$200B))
P/E ratio: 0.1582612365477949
Debt to equity: 0.7473000000000001
Free cash flow (dilution adjusted): 132608096.65112336
Operating income: 108793980.50021195
Net income: 49079058.92327257
Long score: 11 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for KAI (quarterly, report date 2026-03-31)
Altman Z-score: 4.389051832688931 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 7.589286559002451%
Earnings yield: 1.0166087855194883%
Return on net tangible assets: 36.478431676117125%
Capitalized R&D asset: 8094930
ROCI (R&D adjusted): 2.684432526552597%
Rosenberg metric: 0.24597364568081992
Free cash flow margin: 5.59208539812792%
Revenue growth: -1.64183589327892%
Rule of 40 score: 3.950249504849
Market cap: 3688491008 (Mid Cap ($2B-$10B))
P/E ratio: 33.260820045558084
Debt to equity: 0.3611
Free cash flow (dilution adjusted): 15742000
Operating income: 40109000
Net income: 25821000
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for KOV.AX (annual, report date 2025-06-30)
Altman Z-score: 6.513421464554611 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 21.113973227481946%
Earnings yield: 4.595299190975005%
Return on net tangible assets: 21.02571691660089%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 20.753202910982594%
Free cash flow margin: 12.544326241134751%
Revenue growth: 13.930925660185348%
Rule of 40 score: 26.4752519013201
Market cap: 205058752 (Micro Cap ($50M-$300M))
P/E ratio: 5.563526223497529
Debt to equity: 0.23440000000000003
Free cash flow (dilution adjusted): 9803267.973856209
Operating income: 9803921.56862745
Net income: 8599346.405228758
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for LB (quarterly, report date 2026-03-31)
Altman Z-score: 6.53858239181379 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 2.593530839177622%
Earnings yield: 0.9429141069350454%
Return on net tangible assets: 10.515378616400053%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.1719258963716377%
Free cash flow margin: 58.182531124399574%
Revenue growth: -10.167670576631794%
Rule of 40 score: 48.01486054776778
Market cap: 5878708224 (Mid Cap ($2B-$10B))
P/E ratio: 71.0721649484536
Debt to equity: 0.6627
Free cash flow (dilution adjusted): 29676000
Operating income: 29178000
Net income: 17868000
Long score: 6 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for MHJ.AX (annual, report date 2025-06-30)
Altman Z-score: 2.2745608394006416 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 9.88314145959966%
Earnings yield: 7.88950884396635%
Return on net tangible assets: 47.783299225980755%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.148883706345577%
Free cash flow margin: 6.988562587578828%
Revenue growth: -3.483183857025898%
Rule of 40 score: 3.50537873055293
Market cap: 125073840 (Micro Cap ($50M-$300M))
P/E ratio: 13.398692810457515
Debt to equity: 0.8996999999999999
Free cash flow (dilution adjusted): 31628300.437908497
Operating income: 19260882.633986928
Net income: 1477221.3006535945
Long score: 8 | Short score: 1
Recommendation: Long
Stock screener scorecard for NESCO.NS (quarterly, report date 2026-03-31)
Altman Z-score: 7.844906072467435 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 6.247452099470037%
Earnings yield: 0.014371736172218012%
Return on net tangible assets: 3.5639175051242167%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.9863278283570756%
Revenue growth: -3.4445287633295525%
Rule of 40 score: -3.4445287633295525
Market cap: 74398670848 (Large Cap ($10B-$200B))
P/E ratio: 0.18256756980598862
Debt to equity: 0.0907
Operating income: 11043874.52310301
Net income: 9861169.987282747
Long score: 4 | Short score: 4
Recommendation: Neutral